Prognostic value of circulating tumour DNA in metastatic pancreatic cancer patients: post-hoc analys...
Prognostic value of circulating tumour DNA in metastatic pancreatic cancer patients: post-hoc analyses of two clinical trials
About this item
Full title
Author / Creator
Pietrasz, Daniel , Wang-Renault, Shufang , Taieb, Julien , Dahan, Laetitia , Postel, Mathilde , Durand-Labrunie, Jerome , Le Malicot, Karine , Mulot, Claire , Rinaldi, Yves , Phelip, Jean-Marc , Doat, Solene , Blons, Hélène , de Reynies, Aurelien , Bachet, Jean-Baptiste , Taly, Valérie and Laurent-Puig, Pierre
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Objective
The prognostication of metastatic pancreatic adenocarcinoma (mPDAC) patients remains uncertain, mainly based on carbohydrate antigen 19-9 (CA19-9), with limited utility. Circulating tumour DNA (ctDNA) has been suggested as a prognostic factor, but its added value has been poorly explored. The objective was to determine whether ctDNA is...
Alternative Titles
Full title
Prognostic value of circulating tumour DNA in metastatic pancreatic cancer patients: post-hoc analyses of two clinical trials
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8810868
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8810868
Other Identifiers
ISSN
0007-0920
E-ISSN
1532-1827
DOI
10.1038/s41416-021-01624-2
